|
Fischer Medical Ventures Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
5391.55 Cr.
|
P/BV
|
59.55
|
Book Value (Rs.)
|
14.19
|
|
52 Week High/Low (Rs.)
|
859/770
|
FV/ML
|
10/1
|
P/E(X)
|
4,471.16
|
|
Bookclosure
|
17/09/2024
|
EPS (Rs.)
|
0.19
|
Div Yield (%)
|
0.01
|
|
| Months | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 |
| | | | |
| PER SHARE RATIOS | | | |
| | | | |
| Basic EPS (Rs.) | 0.22 | 1.65 | -2.12 |
| Diluted EPS (Rs.) | 0.22 | 1.08 | -2.12 |
| Cash EPS (Rs.) | 0.52 | 0.37 | -2.12 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 52.95 | 15.16 | -15.47 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 52.95 | 15.16 | -15.47 |
| Revenue From Operations / Share (Rs.) | 17.35 | 3.92 | 10.44 |
| PBDIT / Share (Rs.) | 0.75 | 0.44 | 0.88 |
| PBIT / Share (Rs.) | 0.49 | 0.40 | 0.88 |
| PBT / Share (Rs.) | 0.42 | 0.39 | -0.07 |
| Net Profit / Share (Rs.) | 0.26 | 0.34 | -2.12 |
| NP After MI And SOA / Share (Rs.) | 0.18 | 0.34 | -2.12 |
| | | | |
| PROFITABILITY RATIOS | | | |
| | | | |
| PBDIT Margin (%) | 4.34 | 11.25 | 8.46 |
| PBIT Margin (%) | 2.86 | 10.38 | 8.46 |
| PBT Margin (%) | 2.44 | 10.06 | -0.72 |
| Net Profit Margin (%) | 1.53 | 8.75 | -20.33 |
| NP After MI And SOA Margin (%) | 1.09 | 8.75 | -20.33 |
| Return on Networth / Equity (%) | 0.35 | 2.26 | 0.00 |
| Return on Capital Employeed (%) | 0.84 | 2.64 | 4.97 |
| Return On Assets (%) | 0.26 | 2.12 | -10.32 |
| Long Term Debt / Equity (X) | 0.05 | 0.00 | -2.15 |
| Total Debt / Equity (X) | 0.17 | 0.00 | -2.15 |
| Asset Turnover Ratio (%) | 0.40 | 0.48 | 0.00 |
| | | | |
| LIQUIDITY RATIOS | | | |
| | | | |
| Current Ratio (X) | 4.48 | 18.37 | 5.18 |
| Quick Ratio (X) | 4.37 | 17.20 | 5.18 |
| | | | |
| COVERAGE RATIOS | | | |
| | | | |
| Interest Coverage Ratio (%) | 10.30 | 34.92 | 0.92 |
| Interest Coverage Ratio (Post Tax) (%) | 4.63 | 28.19 | -1.21 |
| | | | |
| VALUATION RATIOS | | | |
| | | | |
| Enterprise Value (Cr.) | 5536.51 | 3303.93 | 1.98 |
| EV / Net Operating Revenue (X) | 50.01 | 157.47 | 11.03 |
| EV / EBITDA (X) | 1151.30 | 1399.44 | 130.31 |
| MarketCap / Net Operating Revenue (X) | 51.74 | 159.28 | 8.05 |
| Price / BV (X) | 16.95 | 41.20 | -5.43 |
| Price / Net Operating Revenue (X) | 51.74 | 159.31 | 8.05 |
| EarningsYield | 0.00 | 0.00 | -0.02 |
